Shoulder Innovations received FDA 510(k) clearance to market the InSet Humeral Short Stem system for total and partial shoulder arthroplasty.
The InSet Shoulder features streamlined instrumentation and a proprietary coating for implant fixation. It can be used with the company’s InSet glenoid implant as a bone-sparing option to treat humeral or glenoid deformities.
Last month, the company closed a US $2.5MM round of Series A equity funding to support new product development and growth of its InSet platform, including acquisition of inventory and assets.
Shoulder Innovations received FDA 510(k) clearance to market the InSet Humeral Short Stem system for total and partial shoulder arthroplasty.
The InSet Shoulder features streamlined instrumentation and a proprietary coating for implant fixation. It can be used with the company's InSet glenoid implant as a bone-sparing option to treat humeral...
Shoulder Innovations received FDA 510(k) clearance to market the InSet Humeral Short Stem system for total and partial shoulder arthroplasty.
The InSet Shoulder features streamlined instrumentation and a proprietary coating for implant fixation. It can be used with the company’s InSet glenoid implant as a bone-sparing option to treat humeral or glenoid deformities.
Last month, the company closed a US $2.5MM round of Series A equity funding to support new product development and growth of its InSet platform, including acquisition of inventory and assets.
Copy to clipboard 
